Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,481 to 1,500 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer. | BMC Cancer | 2021 | 33892664 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus. | Biosci Rep | 2021 | 33890634 | PubTator, text mining | PubMed |
| Human Huntington's disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species. | J Neuroinflammation | 2021 | 33874957 | PubTator, text mining | PubMed |
Investigating Mechanisms of Response or Resistance to Immune Checkpoint Inhibitors by Analyzing Cell-Cell Communications in Tumors Before and After Programmed Cell Death-1 (PD-1) Targeted Therapy: An Integrative Analysis Using Single-cell RNA and Bulk-RNA Sequencing Data. | Oncoimmunology | 2021 | 33868792 | PubTator, text mining | PubMed |
| Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction. | Front Immunol | 2021 | 33868315 | PubTator, text mining | PubMed |
| Zika virus infection during pregnancy protects against secondary infection in the absence of CD8+ cells. | Virology | 2021 | 33865073 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 2 Promotes Bladder Hypertrophy Caused by Partial Bladder Outlet Obstruction. | Front Cell Dev Biol | 2021 | 33859983 | PubTator, text mining | PubMed |
| Microglia use TAM receptors to detect and engulf amyloid β plaques. | Nat Immunol | 2021 | 33859405 | PubTator, text mining | PubMed |
| Enhancing the landscape of colorectal cancer using targeted deep sequencing. | Sci Rep | 2021 | 33854094 | PubTator, text mining | PubMed |
| Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass. | Sci Rep | 2021 | 33850249 | PubTator, text mining | PubMed |
| The brominated flame retardants TBECH and DPTE alter prostate growth, histology and gene expression patterns in the mouse. | Reprod Toxicol | 2021 | 33848595 | PubTator, text mining | PubMed |
| Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10. | J Clin Invest | 2021 | 33848267 | PubTator, text mining | PubMed |
| Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis. | Nat Commun | 2021 | 33846348 | PubTator, text mining | PubMed |
| Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression. | Neoplasia | 2021 | 33845354 | PubTator, text mining | PubMed |
| Autophagy and Cancer Dormancy. | Front Oncol | 2021 | 33816262 | PubTator, text mining | PubMed |
| Mumps Orchitis: Clinical Aspects and Mechanisms. | Front Immunol | 2021 | 33815357 | PubTator, text mining | PubMed |
| Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome. | Biomedicines | 2021 | 33810394 | PubTator, text mining | PubMed |
| Zika Virus Pathogenesis: A Battle for Immune Evasion. | Vaccines (Basel) | 2021 | 33810028 | PubTator, text mining | PubMed |
| CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer. | Cancers (Basel) | 2021 | 33808217 | PubTator, text mining | PubMed |
| The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review. | Cells | 2021 | 33807457 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=75